
Eucrisa
My Prescription
Payment
Select pharmacy




$273.14
Print or send this coupon to your phone
About Eucrisa
Drug Details
Eucrisa (crisaborole) is an ointment designed for the treatment of mild-to-moderate eczema in individuals aged 3 months and older. This medication functions as a phosphodiesterase 4 (PDE4) inhibitor, which means it works by blocking the PDE4 enzyme involved in eczema-related skin inflammation. By inhibiting this enzyme, Eucrisa helps to reduce inflammation, redness, and itching associated with eczema. The ointment is typically applied twice daily to the affected skin areas. A common side effect experienced by users is a sensation of burning or stinging at the application site.
Price history for Eucrisa
1 Tube, 100GM of 2%
Average retail price for Eucrisa
Average SaveHealth price for Eucrisa
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Eucrisa dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100GM of 2% | 1 Tube | $1,281.20 | $1,281.20 |
| 100GM of 2% | 2 Tubes | $2,545.39 | $1,272.70 |
| 100GM of 2% | 3 Tubes | $3,809.59 | $1,269.86 |
Eucrisa FAQs
Eucrisa ointment is not a steroid. It is a non-steroidal topical medication used to treat mild to moderate eczema (atopic dermatitis).
Yes, Eucrisa (crisaborole) can have side effects. Common side effects include application site pain, such as burning or stinging. If any severe reactions or unusual symptoms occur, it is important to contact a healthcare provider.
Crisaborole 2% ointment is used for the treatment of mild to moderate atopic dermatitis, also known as eczema, in patients two years of age and older. It helps to reduce inflammation and relieve symptoms such as itching and redness.
Crisaborole ointment is not a steroid. It is a topical phosphodiesterase-4 (PDE-4) inhibitor used to treat mild to moderate atopic dermatitis.
The cost of EUCRISA can be attributed to several factors, including the research and development expenses involved in bringing a new medication to market, the costs associated with clinical trials, and the regulatory approval process. Additionally, pricing can be influenced by the drug's effectiveness, the lack of generic alternatives, and the overall market demand. Pharmaceutical companies also consider the costs of marketing and distribution when setting the price.